Comparison of the Use of Administrative Data and an Active System for Surveillance of Invasive Aspergillosis
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
Background.: Administrative data, such as International Classification of Diseases, Ninth Revision (ICD-9) codes, are readily available and are an attractive option for surveillance and quality assessment within a single institution or for interinstitutional comparisons. To understand the usefulness of administrative data for the surveillance of invasive aspergillosis, we compared information obtained from a system based on ICD-9 codes with information obtained from an active, prospective surveillance system, which used more extensive case-finding methods (Transplant Associated Infection Surveillance Network). Methods.: Patients with suspected inyasive aspergillosis were identified by aspergillosis-related ICD-9 codes assigned to hematopoietic stem cell transplant recipients and solid organ transplant recipients at a single hospital from April 1, 2001, through January 31, 2005. Suspected cases were classified as proven or probable invasive aspergillosis by medical record review using standard definitions. We calculated the sensitivity and positive predictive value (PPV) of identifying invasive aspergillosis by individual ICD-9 codes and by combinations of codes. Results.: The sensitivity of code 117.3 was modest (63% [95% confidence interval {CI}, 38%-84%]), as was the PPV (71% [95% CI, 44%-90%]); the sensitivity of code 117.9 was poor (32% [95% CI, 13%-57%]), as was the PPV (15% [95% CI, 6%-31%]). The sensitivity of codes 117.3 and 117.9 combined was 84% (95% CI, 60%-97%); the PPV of the combined codes was 30% (95% CI, 18%-44%). Overall, ICD-9 codes triggered a review of medical records for 64 medical patients, only 16 (25%) of whom had proven or probable invasive aspergillosis. Conclusions.: A surveillance system that involved multiple ICD-9 codes was sufficiently sensitive to identify most cases of invasive aspergillosis; however, the poor PPV of ICD-9 codes means that this approach is not adequate as the sole tool used to classify cases. Screening ICD-9 codes to trigger a medical record review might be a useful method of surveillance for invasive aspergillosis and quality assessment, although more investigation is needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies have found that ICD-9-CM codes for aspergillosis and candidemia have only modest sensitivity and sometimes poor positive predictive values [26–28].”
From Estimation of Direct Healthcare Costs of Fungal Diseases in the United States (2019) · cites this paper as [27]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 2×
“71 (44-90) 15 (6-31) 88 (47-100) 24 (9-45)”
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448 · cited 1×
“71 (44-90) 15 (6-31) 88 (47-100) 24 (9-45)”
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
Aspergillus Infections in Transplant Recipients
Singh, N., & Paterson, D. L. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.44-69.2005 · Cited by 579 · cited 2×
“71 (44-90) 15 (6-31) 88 (47-100) 24 (9-45)”
Morgan, J., Wannemuehler, K. A., Marr, K. A., Hadley, S., Kontoyiannis, D. P., Walsh, T. J., Fridkin, S. K., Pappas, P. G., & Warnock, D. W. (2005) · Medical Mycology · doi:10.1080/13693780400020113 · Cited by 407 · cited 1×
“71 (44-90) 15 (6-31) 88 (47-100) 24 (9-45)”
Self-citationSchneider, E. C., & Epstein, A. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350406 · Cited by 396 · cited 2×
“71 (44-90) 15 (6-31) 88 (47-100) 24 (9-45)”
Invasive Aspergillosis in Transplant Recipients
Paterson, D. L., & Singh, N. (1999) · Medicine · doi:10.1097/00005792-199903000-00003 · Cited by 359
Minari, A., Husni, R., Avery, R. K., Longworth, D. L., DeCamp, M., Bertin, M., Schilz, R., Smedira, N., Haug, M. T., Mehta, A., et al. (2002) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2002.t01-2-02002.x · Cited by 351
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
Jantunen, E., Ruutu, P., Niskanen, L., Volin, L., Parkkali, T., Koukila-Kähkölä, P., & Ruutu, T. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700737 · Cited by 251 · cited 1×
“71 (44-90) 15 (6-31) 88 (47-100) 24 (9-45)”
Outmigration For Coronary Bypass Surgery in an Era of Public Dissemination of Clinical Outcomes
Omoigui, N. A., Miller, D. P., Brown, K. J., Annan, K., Cosgrove, D., Lytle, B., Loop, F., & Topol, E. J. (1996) · Circulation · doi:10.1161/01.cir.93.1.27 · Cited by 232 · cited 2×
“71 (44-90) 15 (6-31) 88 (47-100) 24 (9-45)”
Cited by
Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
“Furthermore, retrospective assessment of the incidence of IFIs with use of discharge databases or death records relies on insufficient data that could lead to inaccurate estimates, especially with respect to invasive mold infections [19, 20].”
BackgroundSelf-citationEstimation of Direct Healthcare Costs of Fungal Diseases in the United States
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438
Self-citationIncreasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006
Bitar, D., Van Cauteren, D., Lanternier, F., Dannaoui, E., Che, D., Dromer, F., Desenclos, J.-C., & Lortholary, O. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.090334 · Cited by 429
“(27), who compared administrative data with medical records in the United States, the positive predictive value of ICD-10 codes for detecting invasive aspergillosis can be low.”
BackgroundPopulation-Based Analysis of Invasive Fungal Infections, France, 2001–2010
Bitar, D., Lortholary, O., Le Strat, Y., Nicolau, J., Coignard, B., Tattevin, P., Che, D., & Dromer, F. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.140087 · Cited by 426
“Despite potential bias in the precise classification of cases, particularly for mold infections, and other limitations of administrative datasets that have been previously discussed (12,14,16), several points validate the findings obtained through this large database.”
Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006
Park, B. J., Pappas, P. G., Wannemuehler, K. A., Alexander, B. D., Anaissie, E. J., Andes, D. R., Baddley, J. W., Brown, J. M., Brumble, L. M., Freifeld, A. G., et al. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110087 · Cited by 321
“Further study of the seasonal risk for rare mold infections such as these most likely necessitates a larger cohort than that from TRANSNET; large national databases, including those using administrative codes, despite their poor predictive values (28), might be promising for estimating trends for such diseases.”
BackgroundSelf-citationEpidemiology of cryptococcal meningitis in the US: 1997–2009
Pyrgos, V., Seitz, A. E., Steiner, C. A., Prevots, D. R., & Williamson, P. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056269 · Cited by 309
“Misclassification using codes is likely to be greatest for diseases that are challenging to diagnose or require empiric therapy often without microbiological diagnoses [38,39].”
Geographic Distribution of Endemic Fungal Infections among Older Persons, United States
Baddley, J. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1709.101987 · Cited by 177
Jetté, N., Quan, H., Hemmelgarn, B., Drosler, S., Maass, C., Moskal, L., Paoin, W., Sundararajan, V., Gao, S., Jakob, R., et al. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181ef9d3e · Cited by 173
Burden of Candidemia in the United States, 2017
Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa193 · Cited by 163
Self-citationMenzin, J., Meyers, J. L., Friedman, M., Perfect, J. R., Langston, A. A., Danna, R. P., & Papadopoulos, G. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080325 · Cited by 151
Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
Baddley, J. W., Stephens, J. M., Ji, X., Gao, X., Schlamm, H. T., & Tarallo, M. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-29 · Cited by 145
“Nevertheless, as a recent validation study reported, specificity using ICD-9 codes for aspergillosis ranges from 28-88% [16].”
BackgroundHosseini-Moghaddam, S. M., Ouédraogo, A. M., Naylor, K. L., Bota, S. E., Husain, S., Nash, D. M., & Paterson, J. M. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13250 · Cited by 91
Ananda-Rajah, M. R., Cheng, A., Morrissey, C. O., Spelman, T., Dooley, M., Neville, A. M., & Slavin, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01423-10 · Cited by 84
“These studies (16, 20, 31), like others now 10 years old (8, 27, 28, 35), used administrative data sets, which have poor case detection (6); in our case, an administrative IFD diagnosis was absent for 13 possible case patients.”
MethodFung, M., Jacobsen, E. D., Freedman, A. S., Prestes, D., Farmakiotis, D., Gu, X., Nguyen, P. L., & Koo, S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy458 · Cited by 66
Zilberberg, M. D., Nathanson, B. H., Harrington, R., Spalding, J. R., & Shorr, A. F. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy181 · Cited by 62
“6, shown to be sensitive in detecting IA [12].”
BackgroundMethodResultValentine, J. C., Morrissey, C. O., TACEY, M. A., Liew, D., Patil, S. S., Peleg, A. Y., & Ananda-Rajah, M. R. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3901-y · Cited by 62
Necessity and Implications of ICD-10: Facts and Fallacies
Manchikanti, L., Falco, F. J. E., & Hirsch, J. A. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/e405 · Cited by 62
Future Directions in Mucormycosis Research
Kontoyiannis, D. P., Lewis, R. E., Lotholary, O., Spellberg, B. J., Πετρίκκος, Γ., Roilides, E., Ibrahim, A. S., & Walsh, T. J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir886 · Cited by 56
“Also, difficulties in diagnosis of mucormycosis in the current era of very low autopsy rates [4] and relative inaccuracy of hospital discharge codes [5] make assessment of the true burden of this infection challenging.”
González, O. R., Tenías, J. M., Arias, Á., & Lucendo, A. J. (2017) · Health Services Research · doi:10.1111/1475-6773.12691 · Cited by 43
“…Curtis et al. 2004; Dubberke et al. 2006; Scheurer et al. 2007; Azaouagh and Stausberg 2008; Stausberg and Azaouagh 2008; Stevenson et al. 2008; Chang et al. 2008; Bolon et al. 2009; Schmiedeskamp et al. 2009; Zhan et al. 2009; Olsen and Fraser 2010; Schaefer et al. 2010; Verelst et al. 2010;…”
Five-years surveillance of invasive aspergillosis in a university hospital
Graf, K., Khani, S. M., Ott, E., Mattner, F., Gastmeier, P., Sohr, D., Ziesing, S., & Chaberny, I. F. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-163 · Cited by 35
“There are other simplified surveillance methods in place, but they showed to be suitable for special patient groups only, while further clarification often remains impossible due to the lack of additional clinical data [14].”
Martínez, D., Ananda-Rajah, M. R., Suominen, H., Slavin, M. A., Thursky, K., & Cavedon, L. (2014) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.11.009 · Cited by 37
“Thus, traditional methods of surveillance using either clinical review, laboratory-based methods, or less commonly administrative data are costly, labour intensive, error prone, and subject to incomplete case findings [9,27].”
MethodInfluenza-Associated Aspergillosis
Sharma, A., Mishra, T., Kumar, N., & Soubani, A. O. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.06.010 · Cited by 28
The U.S. Food and Drug Administration's Mini‐Sentinel Program
Platt, R. G., & Carnahan, R. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3230 · Cited by 31
Bitar, D., Morizot, G., Cauteren, D. V., Dannaoui, É., Lanternier, F., Lortholary, O., & Dromer, F. (2012) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2012.03.007 · Cited by 23
Ananda-Rajah, M. R., Bergmeir, C., Petitjean, F., Slavin, M. A., Thursky, K., & Webb, G. I. (2017) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00011 · Cited by 23
Patel, D. A., Gao, X., Stephens, J., Forshag, M. S., & Tarallo, M. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.564246 · Cited by 24
Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004–2013
Zilberberg, M. D., Harrington, R. L., Spalding, J. R., & Shorr, A. F. (2019) · BMC Public Health · doi:10.1186/s12889-019-6932-9 · Cited by 20
Bardach, N. S., Huang, J., Brand, R., & Hsu, J. T.-A. (2009) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-9-35 · Cited by 19
Ananda-Rajah, M. R., Martínez, D., Slavin, M. A., Cavedon, L., Dooley, M. J., Cheng, A., & Thursky, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107797 · Cited by 18
“Adminis-trative data such as coding diagnoses is unreliable for IMD surveillance [18] and neither timely nor informative enough for outbreak detection.”
BackgroundMethodValentine, J. C., Morrissey, C. O., TACEY, M. A., Liew, D., Patil, S. S., & Ananda-Rajah, M. R. (2019) · Mycoses · doi:10.1111/myc.13033 · Cited by 16
“05), followed by mucormycosis (cases: 55 [48-73] days, controls: 52 [23-82]; P = .”
MethodInfluentialValentine, J. C., Worth, L. J., Verspoor, K. M., Hall, L., Yeoh, D. K., Thursky, K., Clark, J. E., & Haeusler, G. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238889 · Cited by 13
“Current surveillance of IFI is manual, onerous, time-consuming and resource-intensive [1, 2, 4, 12, 24].”
BackgroundToda, M., Benedict, K., & Jackson, B. R. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab091 · Cited by 14
“Distinguishing between invasive and noninvasive aspergillosis is particularly difficult based on ICD codes alone [30].”
BackgroundÉpidémiologie des mucormycoses en France métropolitaine, 1997–2010
Bitar, D., & Che, D. (2013) · médecine/sciences · doi:10.1051/medsci/201329s103 · Cited by 13
“En effet, les biais de classification sont fréquents dans les bases médico-administratives, surtout pour des pathologies rares, peu connues [15-17].”
BackgroundEpidemiology of Systemic Fungal Diseases: An Overview
Park, B. J., Chiller, T. M., Brandt, M. E., & Warnock, D. W. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_2 · Cited by 15
“However, since administrative data are usually coded by personnel who are trained for reimbursement purposes, these criteria have been shown to have poor predictive value for fungal diseases, such as aspergillosis, when used as a case definition [44].”
BackgroundSelf-citationCarnahan, R. M., Moores, K. G., & Perencevich, E. N. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2332 · Cited by 9
“Algorithm Validation Studies Citation Study population and time period Description of outcome studied Algorithm Validation/adjudication procedure, operational definition, and validation statistics Chang et al.(9) All patients who received solid organ or hematopoietic stem cell transplants (HSCT) at a large academic me…”
MethodChen, Y.-J., Lin, I., Chuang, J.-H., Huang, H., & Chan, T. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2155584 · Cited by 9
“IA was de fi ned as the fi rst hospitalization with aspergillosis (International Classi fi cation of Diseases, Ninth Revision [ICD-9] codes 117.3, 484.6; ICD-10 codes B44) during the follow-up period and without any IA diagnosis before the in fl uenza season [19].”
MethodInfluentialBenedict, K., Jackson, B. R., & Toda, M. (2023) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2023.28 · Cited by 7
“15,16 In conclusion, ICD-10-CM codes alone were insufficient for identifying any potential increase in IMI after Hurricane Harvey in this privately insured population.”
Waller, K. M. J., Mata, N. L. D. L., Hedley, J., Rosales, B. M., O’Leary, M. J., Cavazzoni, E., Ramachandran, V., Rawlinson, W. D., Kelly, P. J., Wyburn, K., et al. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13437 · Cited by 6
“Median (IQR) 50 (36-58) 53 (43-59) 50 (36-58)”
Li, L. X., Xue, J., Chiang, T. P., Lu, N., Ostrander, D. B., Zhang, S. X., Baddley, J. W., Shoham, S., Brennan, D. C., Durand, C. M., et al. (2025) · American Journal of Transplantation · doi:10.1016/j.ajt.2025.03.030 · Cited by 4
Aspergillosis-Attributable Mortality in the United States: Analysis of Death Certificate Data
Walsh, T. J., Sicignano, D. J., Mastropietro, M., Lovelace, B., & Coleman, C. I. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf653 · Cited by 2
Mould-Quevedo, J. F., Contreras-Hernández, I., Gómez‐Morales, E., Mejía‐Aranguré, J. M., & Garduño‐Espinosa, J. (2009) · Boletín Médico del Hospital Infantil de México · Cited by 2
Epidemiology of Aspergillosis Diagnoses in US Adults Using a National EHR Database, 2013–2023
Bustamante, B. L. M., Martinez, E. G., Lee, A., Kane, N. J., Camponuri, S. K., Reynolds, R. M., Snow, T. T., Bartels, J., Hoffman, M. A., White, T. C., et al. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag094 · Cited by 6
“Prior studies have largely been limited to insured populations [17, 21], inpatient vs outpatient comparisons [22], specific disease states [10, 23, 24], and state-or facility-specific assessments [25–27].”
Epidemiologic Research of Invasive Fungal Infections Using Large Healthcare Databases
Min, Z., Curtis, J. R., & Baddley, J. W. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0156-8 · Cited by 1
Panackal, A. A. (2010) · Medical Mycology · doi:10.3109/13693780903262105 · Cited by 1
Epidemiology of Aspergillosis Diagnoses in the U.S. using a National EHR Database, 2013-2023Preprint
Bustamante, B. L. M., Martinez, E. G., Lee, A., Kane, N. J., Camponuri, S. K., Reynolds, R. M., Snow, T. T., Bartels, J. G. E., Hoffman, M. A., White, T. C., et al. (2025) · medRxiv · doi:10.1101/2025.06.19.25329882 · Cited by 1
Lefebvre, M., Robinson, J. L., Winters, N., Allen, U., Buteau, C., Embreé, J., Gagneur, A., Hamilton, N., Hui, C. P., Langley, J. M., et al. (2017) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.2.1.003
133. ハウレットチャートを用いた DSA の画像評価 第 1 報(画像評価-1 ディジタル画像評価)
小林, 敬., 山下, 肇., 吉川, 東., 鈴木, 敦., 小口, 真., & 船木, 新. (1992) · 日本放射線技術學會雜誌
Using Machine Learning Algorithms to Identify Key Predictors of Invasive Mold Infection Surveillance
Williams, S., Salah, Z., Jackson, B. R., Wurster, S., Serpa, J. A., Grimes, C. Z., Atmar, R. L., Chiller, T. M., Kontoyiannis, D. P., Ostrosky-Zeichner, L. L., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf219
Self-citationChan, S., Stoudenmire, L. L., Chen, X., Zhan, D., Henao‐Martínez, A. F., & Chastain, D. B. (2025) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361251347778
He, C., Liu, X., Wang, B., Hu, L., Zhang, J., Zeng, X., & Wan, B. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-14059-y
“…case ascertainment can also have limited accuracy: administrative or coding data have shown positive predictive values of approximately 30% for invasive aspergillosis [15], 60% for invasive fungal infection in paediatric cancer [16], and 20% for health-care-associated infection more broadly [17].”
Montoya, M. C., Esquivel, B. D., Hoffman, M. A., Remais, J. V., & White, T. C. (2026) · Journal of Fungi · doi:10.3390/jof12100752
“Mucorales underwent expansion in ICD–10 with the addition of codes specifying new body sites and fungal etiology, but ultimately only the latter were preserved.”
Metadata
- Authors
- Chang, D. C., Burwell, L. A., Lyon, G. M., Pappas, P. G., Chiller, T. M., Wannemuehler, K. A., Fridkin, S. K., & Park, B. J.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- University of Alabama (US)
- Corresponding author
- Chang, Douglas C.
- Park, Benjamin J.
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-01
- Volume
- 29
- Issue
- 1
- Pages
- 25-30
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W2060907739
- Semantic Scholar
- 5c66e510e4cd4c6eea7d29dd6e830aeb45902fe4
- Cited by
- 51
- References
- 18
- Citations by year
- 2026: 3 · 2025: 5 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 3 · 2014: 3 · 2013: 4 · 2012: 4
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Infection Control and Hospital Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Alabama at Birmingham
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- invasive aspergillosis, administrative data, ICD-9 codes, hematopoietic stem cell transplant recipients, solid organ transplant recipients, case finding, sensitivity and positive predictive value, medical records review, quality assessment, fungal infection surveillance, ICD-10 implementation
- MeSH terms
- Adolescent, Adult, Aged, Aspergillosis, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Sensitivity and Specificity, Transplantation, Medical Records Systems, Computerized, Hematopoietic Stem Cell Transplantation, Sentinel Surveillance, International Classification of Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.